LDLR and neoplasm: A chemotherapeutic agent, with a lipid moiety, results in higher lipophilicity and metabolic stability of the parent drug, which can facilitate cellular uptake via passive diffusion, particularly in cases when there is overexpression of low-density lipoprotein (LDL) receptors on tumor cells.